<VariationArchive RecordType="classified" VariationID="1703003" VariationName="NM_001242882.2(NAXD):c.102_103del (p.Thr35fs)" VariationType="Deletion" Accession="VCV001703003" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-03" DateCreated="2022-08-29" MostRecentSubmission="2022-08-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1695395" VariationID="1703003">
      <GeneList>
        <Gene Symbol="NAXD" FullName="NAD(P)HX dehydratase" GeneID="55739" HGNC_ID="HGNC:25576" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="110615460" stop="110639996" display_start="110615460" display_stop="110639996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="111267806" stop="111292342" display_start="111267806" display_stop="111292342" Strand="+" />
          </Location>
          <OMIM>615910</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001242882.2(NAXD):c.102_103del (p.Thr35fs)</Name>
      <CanonicalSPDI>NC_000013.11:110622269:ATA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="110622270" stop="110622271" display_start="110622270" display_stop="110622271" variantLength="2" positionVCF="110622269" referenceAlleleVCF="AAT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="111274617" stop="111274618" display_start="111274617" display_stop="111274618" variantLength="2" positionVCF="111274616" referenceAlleleVCF="AAT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T35fs</ProteinChange>
      <ProteinChange>T53fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.111274618_111274619del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.111274618_111274619del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.110622271_110622272del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.110622271_110622272del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242881.2" sequenceAccession="NM_001242881" sequenceVersion="2" change="c.156_157del">
            <Expression>NM_001242881.2:c.156_157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229810.1" sequenceAccession="NP_001229810" sequenceVersion="1" change="p.Thr53fs">
            <Expression>NP_001229810.1:p.Thr53fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242882.2" sequenceAccession="NM_001242882" sequenceVersion="2" change="c.102_103del" MANESelect="true">
            <Expression>NM_001242882.2:c.102_103del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229811.1" sequenceAccession="NP_001229811" sequenceVersion="1" change="p.Thr35fs">
            <Expression>NP_001229811.1:p.Thr35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018210.4" sequenceAccession="NM_018210" sequenceVersion="4" change="c.156_157del">
            <Expression>NM_018210.4:c.156_157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060680.2" sequenceAccession="NP_060680" sequenceVersion="2" change="p.Thr53fs">
            <Expression>NP_060680.2:p.Thr53fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040103.1" sequenceAccession="NR_040103" sequenceVersion="1" change="n.244_245del">
            <Expression>NR_040103.1:n.244_245del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040104.1" sequenceAccession="NR_040104" sequenceVersion="1" change="n.244_245del">
            <Expression>NR_040104.1:n.244_245del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242883.2" sequenceAccession="NM_001242883" sequenceVersion="2" change="c.57-5168_57-5167del">
            <Expression>NM_001242883.2:c.57-5168_57-5167del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="615910.0007" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 615910.0007 from the sequence reported in the supplementary material of the paper by Zhou et al., 2020 (PubMed 31755961).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001242882.2(NAXD):c.102_103del (p.Thr35fs) AND NAD(P)HX dehydratase deficiency" Accession="RCV002279911" Version="1">
        <ClassifiedConditionList TraitSetID="46379">
          <ClassifiedCondition DB="MedGen" ID="C5193026">NAD(P)HX dehydratase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-08-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-29" MostRecentSubmission="2022-08-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31755961</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="46379" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41365" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NAD(P)HX dehydratase deficiency</ElementValue>
                <XRef ID="MONDO:0034121" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEBEL2</ElementValue>
                <XRef Type="MIM" ID="618321" DB="OMIM" />
              </Symbol>
              <XRef ID="555402" DB="Orphanet" />
              <XRef ID="C5193026" DB="MedGen" />
              <XRef ID="MONDO:0034121" DB="MONDO" />
              <XRef Type="MIM" ID="618321" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5021766" SubmissionDate="2022-08-26" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="615910.0007_ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" title="NAXD, 2-BP DEL, 101TA_ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" />
        <ClinVarAccession Accession="SCV002568013" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Chinese boy with early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy-2 (PEBEL2; 618321), Zhou et al. (2020) identified compound heterozygous mutations in the NAXD gene: a 2-bp deletion (c.101_102delTA, NM_001242882.1), resulting in a frameshift and premature termination (Thr35PhefsTer63), and a c.318C-G transversion, resulting in an ile106-to-met (I106M; 615910.0008) substitution at a conserved residue. The mutations were identified by trio whole-exome sequencing and confirmed by Sanger sequencing. The c.101_102delTA mutation was not reported in the gnomAD database, and the I106M mutation was reported in the gnomAD database with an allele frequency of 7.97 x 10(-6) with no homozygotes, but was not identified in 508 alleles from Chinese patients. Functional studies were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">31755961</ID>
              </Citation>
              <XRef DB="OMIM" ID="618321" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <Name>NAXD, 2-BP DEL, 101TA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 101TA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="615910.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5021766" TraitType="Disease" MappingType="Name" MappingValue="ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" MappingRef="Preferred">
        <MedGen CUI="C5193026" Name="NAD(P)HX dehydratase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

